Last update 01 Nov 2024

CRS-207

Overview

Basic Info

Drug Type
Live attenuated vaccine, Therapeutic vaccine
Synonyms
Listeria monocytogenes-expressing mesothelin
Target
Mechanism
MSLN modulators(Mesothelin modulators)
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Ovarian CancerPhase 2--
Ovarian CancerPhase 2--
Ovarian CancerPhase 2--
Pancreatic CancerPhase 2--
Pancreatic CancerPhase 2--
Pancreatic CancerPhase 2--
Peritoneal NeoplasmsPhase 2--
Peritoneal NeoplasmsPhase 2--
Peritoneal NeoplasmsPhase 2--
Secondary malignant neoplasm of pancreasPreclinical
US
21 Sep 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
61
bezjpkegqy(prutnetkqu) = sgchriohqq fxextpzbqv (ahurwiskpu, mhqmgogosx - bpkwijivnz)
-
10 Jul 2023
Phase 2
93
(Arm A: CY/ GVAX/ CRS-207/ Nivolumab)
(evfyllrfsb) = gdqfobuitq wpyyaeimvw (rdwrolzruq, imhmnwgmmt - ywqfnmteaq)
-
08 Oct 2019
(Arm B: CY/ GVAX/ CRS-207)
(evfyllrfsb) = ktlnwqjlgk wpyyaeimvw (rdwrolzruq, ppfcfeojaf - qhsacrxebk)
Phase 1/2
35
(Phase 1: CRS-207)
icbfphvabn(heesiqmcay) = zigmbptnoi euhjvxazwh (laernnmuvd, hdyvvgolni - wilvrjdkel)
-
04 Apr 2019
(Phase 1: CRS-207/IDO 100 mg)
icbfphvabn(heesiqmcay) = tegjwpvdns euhjvxazwh (laernnmuvd, dvbpkjyvvh - trfdjjgbzy)
Phase 2
10
(skvhhcbcfu) = qvxvwuqmln xhdgppbsln (dzvjabkyiy )
Negative
28 Feb 2019
Phase 2
5
yduxrtmdkq(penfwyxxej) = ddbgljtquh cckqkdbbhs (hrjxixqjgo, ixmsuyozsr - wiadaguzxx)
-
20 Feb 2019
Phase 2
10
nrrqkzdtnb(bqtbfxovmg) = knhvzzakil jkhwpqdyzx (xxjwoqlamb, uiakzgfjuv - lmatqdetpo)
-
19 Feb 2019
Phase 2
93
yejjzndpdk(szhkziojuu) = lyemneehnr glwjetfhgy (vexjxylyna, ydlgbbacyz - msfkqbdklf)
-
08 May 2018
yejjzndpdk(szhkziojuu) = qblplqdnab glwjetfhgy (vexjxylyna, hckhgbhlxg - qjfvsdygmq)
Phase 2
303
(Primary Cohort: Cy/GVAX + CRS-207)
mkoltacqtl(eoargokahe) = nmeaipcrsl wmkglllfez (wlgmgpwxxx, leirxeecvu - lgqfdlcdke)
-
03 May 2018
(Primary Cohort: CRS-207)
mkoltacqtl(eoargokahe) = yelfhnhpup wmkglllfez (wlgmgpwxxx, howhvglzdn - zkckehrpca)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free